Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 804 results for "cadila pharmaceutical"

More gains ahead for pharma stocks

Related to : Lupin Ltd,Cadila Healthcare Ltd Lupin Ltd BSE 24 Mar 15 | 10:17 AM 1963.00 41.45 (2.16%) NSE 24 Mar 15 | 10:10 AM 1953.50 32 (1.67%) Pharma stocks including the likes of Lupin, Sun Pharma, Dr Reddy's saw a bit of a ... Smart Investor, 6 days ago

19 images for cadila pharmaceutical

Money Control, 3 days ago
Financial Express, 4 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago

Three investors meet Chouhan

stors met Chief Minister Shivraj Singh Chouhan at Mantralaya on Wednesday. They included CMD of Cadila Pharmaceuticals Rajiv Modi, Rajesh Alareja from Chicago and Chairman of Pression Segal Washington Sanjay Puri. Industries Minister Yashodhara Raje ...
 New Delhi Pioneer5 days ago

Cadila Pharma to observe World TB Day

Cadila Pharmaceuticals Ltd is planning various activities across West Bengal to raise awareness about Tuberculosis on World TB Day tomorrow. The activities will engage doctors, hospitals, medical colleges and youth through awareness rallies and ...
 The Echo Of India1 week ago Cadila Pharmaceuticals to observe World TB Day  Financial Express6 days ago Dy. CM and Industries Minister of Telangana appreciate Cadila Pharmaceuticals  India Infoline2 months ago

Cadila Healthcare Q3 net profit up

Cadila Healthcare Limited, a manufacturer of active pharmaceutical ingredients and finished dosage formulations, has reported that net profit for the third quarter ended December 31, 2014 was INR2.96 billion, or INR13.77 per share, compared to ...
 Individual.com1 month ago Cadila Healthcare spurts on launching SoviHep  Capital Market1 week ago Cadila Healthcare bucks trend on strong Q3 earnings  Capital Market1 month ago Cadila Healthcare Q3 profit may jump 55% to Rs 288 cr: Poll  Moneycontrol.com1 month ago

Zydus Cadila Launches Generic Version of Gilead Sciences Hepatitis C drug in India

Pharmaceutical companies across the globe have been spending lot of money in research to find out effective treatments for Hepatitis C. In India, more than 10 million people suffer from Hepatitis C, which was earlier considered to be an incurable ...
 Topnews.in1 week ago Natco launches first generic of Hepatitis C drug Sovaldi  India Brand Equity Foundation2 weeks ago Natco Pharma launches Hepatitis-C drug Sovaldi in Nepal  The Financial Chronicle3 weeks ago US-India War over Pharmaceuticals Heats Up  Asia Sentinel1 month ago

FTSE adds nine Indian firms to key Asia-Pac index

BY PTI The firms include Aurobindo Pharma, Yes Bank, Eicher, Motherson Sumi, Zee, Godrej Cons, Shree Cements, Cadila and Bosch. Nine Indian companies, including Bosch, Aurobindo Pharmaceuticals and Yes Bank, will be included in the ...
 VC Circle3 weeks ago FTSE adds 9 Indian firms to key Asia Pacific index  Economic Times3 weeks ago Select shares mixed after rejig in FTSE indices  Capital Market3 weeks ago

Cadila Pharmaceuticals organises Ashtavakra Gita Chintan Satra

Ahmedabad, Ashtavakra Gita is considered one of the most celebrated scriptures narrating philosophy of life and its various aspects. It is a dialogue between Rishi Ashtavakra and King Janak wherein King Janak asks various questions on intricacies ...
 DeshGujarat1 month ago

Zydus completes Phase I studies on molecule for treating anemia

City-based pharmaceutical major, Zydus Cadila announced completion of the single ascending dose (SAD) study of ZYAN1 molecule as part of phase-1 study ongoing in Australia. The molecule, ZYAN1 is an orally bioavailable hypoxia-inducible ...
 Hindu Business Line1 month ago Zydus completes single ascending dose Phase I trial of anaemia drug ZYAN1  Pharmaceutical Business Review1 month ago Zydus Cadila completes single ascending dose Phase I anemia studies  Individual.com1 month ago Zydus completes phase I studies of ZYAN1 for treating anaemia  PharmaBiz1 month ago

Zydus Wellness plans new launches under Everyuth

The consumer products arm of Ahmedabad-based pharmaceutical major Cadila Healthcare, Zydus Wellness, is planning to up its ante in the personal care segment where it sells its products under the Everyuth brand. The company which has recently ...
 Business Standard India1 month ago Zydus Wellness launches herbal variant of Sugar Free  Smart Investor1 month ago

CADILA HEALTHCARE : Patent Application Titled "Pharmaceutical Compositions of Sodium Picosulfate, Magnesium Oxide and Citric Acid" Published Online

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors ESSAKIMUTHU, Kannan Muthaiyyan (Ahmedabad, IN); PATEL, Jitendra ...
 4 Traders5 days ago CADILA HEALTHCARE : Researchers Submit Patent Application, "Method for Treatment of Pain and Inflammation", for Approval  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less